Cargando…
KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?
BACKGROUND: Glioblastomas (GBM) are typically comprised of morphologically diverse cells. Despite current advances in therapy, including surgical resection followed by radiation and chemotherapy, the prognosis for patients with GBM remains poor. Unfortunately, most patients die within 2 years of dia...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711111/ https://www.ncbi.nlm.nih.gov/pubmed/19545421 http://dx.doi.org/10.1186/1471-2407-9-196 |